Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1971 Feb;41(2):239–255. doi: 10.1111/j.1476-5381.1971.tb08025.x

Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation

J Hughes, R H Roth
PMCID: PMC1703258  PMID: 4324592

Abstract

1. The effects of angiotensin on the contractility of the transmurally stimulated rabbit portal vein and coeliac artery have been studied in conjunction with its effects on the release and uptake of (±)-3H-noradrenaline.

2. Angiotensin contracted both vein and artery; these responses were enhanced by veratrine and reduced by tetradotoxin. At low (non-contractile) concentrations of angiotensin, contractions elicited by electrical stimulation (0·5-4 Hz) had a quicker onset and reached a higher maximal tension than control responses. Higher concentrations of angiotensin increased the degree of potentiation. Contractions to noradrenaline were not enhanced by angiotensin.

3. Pretreatment of the coeliac artery, portal vein and perfused rat heart with angiotensin did not reduce the subsequent uptake of labelled noradrenaline in the presence of angiotensin. Simultaneous treatment with angiotensin and 3H-noradrenaline caused a small, apparent inhibition of uptake into the portal vein.

4. When the portal vein was incubated with 3H-noradrenaline there was a marked accumulation of label within the tissue; over 90% of the radioactivity retained in the tissue was identified as intact noradrenaline. When the vein, or artery, was superfused with amine-free Krebs there was a steady basal release of label; the greater proportion of this label was identified as deaminated metabolites. Electrcal stimulation evoked a frequency dependent release of 3H above basal levels. The greater proportion of this increased efflux was due to the release of intact 3H-noradrenaline, with smaller increases in the amount of O-methylated and deaminated metabolites.

5. Angiotensin increased the efflux of labelled noradrenaline + normetanephrine, or of total 3H, during transmural stimulation (0·5-4 Hz) in both the vein and artery, but did not increase the efflux of deaminated products during electrical stimulation. The output of labelled noradrenaline + normetanephrine was usually doubled in the presence of angiotensin (200-500 ng/ml) during electrical stimulation of the portal vein.

6. Cocaine (4 μg/ml) potentiated responses to noradrenaline and transmural stimulation, and doubled the output of 3H or labelled noradrenaline + nor-metanephrine during electrical stimulation. Cocaine did not alter the potentiating effects of angiotensin.

7. Angiotensin elicited transitory increases in the basal efflux of 3H from both the portal vein and coeliac artery. However, this did not account for the marked increase in efflux seen during electrical stimulation. Vasopressin did not potentiate responses to transmural stimulation or significantly influence the efflux of 3H from the vein or artery.

8. Noradrenaline and 5-hydroxytryptamine, but not acetylcholine, markedly increased the efflux of 3H from the portal vein. This increase in efflux of label is believed to result from an exchange of exogenous noradrenaline and 5-hydroxytryptamine with labelled tissue stores of noradrenaline.

9. It is suggested that angiotensin is able to facilitate the release of the sympathetic transmitter and that this is the basis for its action in potentiating the responses to sympathetic stimulation. It is also suggested that the nor-adrenaline releasing action of angiotensin (by excitation of sympathetic nerve endings) has led to confusion in previous investigations of the effects of angiotensin on noradrenaline uptake.

Full text

PDF
239

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENELLI G., DELLABELLA D., GANDINI A. ANGIOTENSIN AND PERIPHERAL SYMPATHETIC NERVE ACTIVITY. Br J Pharmacol Chemother. 1964 Feb;22:211–219. doi: 10.1111/j.1476-5381.1964.tb01561.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boadle M. C., Hughes J., Roth R. H. Angiotensin accelerates catecholamine biosynthesis in sympathetically innervated tissues. Nature. 1969 Jun 7;222(5197):987–988. doi: 10.1038/222987a0. [DOI] [PubMed] [Google Scholar]
  3. Crocker A. D., Munday K. A. The effect of the renin-angiotensin system on mucosal water and sodium transfer in everted sacs of rat jejunum. J Physiol. 1970 Feb;206(2):323–333. doi: 10.1113/jphysiol.1970.sp009015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Day M. D., Owen D. A. Potentiation by angiotensin of responses to endogenously released noradrenaline in the pithed rat. Arch Int Pharmacodyn Ther. 1969 Jun;179(2):469–479. [PubMed] [Google Scholar]
  5. Distler A., Liebau H., Wolff H. P. Action of angiotensin on sympathetic nerve endings in isolated blood vessels. Nature. 1965 Aug 14;207(998):764–765. doi: 10.1038/207764a0. [DOI] [PubMed] [Google Scholar]
  6. Hughes J., Roth R. H. Enhanced release of transmitter during sympathetic nerve stimulation in the presence of angiotensin. Br J Pharmacol. 1969 Oct;37(2):516P–517P. [PMC free article] [PubMed] [Google Scholar]
  7. Kiran B. K., Khairallah P. A. Angiotensin and norepinephrine efflux. Eur J Pharmacol. 1969 May;6(2):102–108. doi: 10.1016/0014-2999(69)90204-0. [DOI] [PubMed] [Google Scholar]
  8. PATON W. D., VANE J. R. Analysis of he responses of the isolated stomach to electrical stimulation and to drugs. J Physiol. 1963 Jan;165:10–46. doi: 10.1113/jphysiol.1963.sp007040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Palaic D., Khairallah P. A. Inhibition of noradrenaline uptake by angiotensin. J Pharm Pharmacol. 1967 Jun;19(6):396–397. doi: 10.1111/j.2042-7158.1967.tb09567.x. [DOI] [PubMed] [Google Scholar]
  10. Pals D. T., Masucci F. D. Effect of cocaine, desipramine and angiotensin on uptake of noradrenaline in tissues of pithed rats. Nature. 1968 Feb 24;217(5130):772–773. doi: 10.1038/217772a0. [DOI] [PubMed] [Google Scholar]
  11. Panisset J. C., Bourdois P. Effect of angiotensin on the response to noradrenaline and sympathetic nerve stimulation, and on 3H-noradrenaline uptake in cat mesenteric blood vessels. Can J Physiol Pharmacol. 1968 Mar;46(2):125–131. doi: 10.1139/y68-021. [DOI] [PubMed] [Google Scholar]
  12. Peach M. J., Bumpus F. M., Khairallah P. A. Inhibition of norepinephrine uptake in hearts by angiotensin II and analogs. J Pharmacol Exp Ther. 1969 Jun;167(2):291–299. [PubMed] [Google Scholar]
  13. Peach M. J., Ford G. D. The actions of angiotensin II on canine myocardial and plasma catecholamines. J Pharmacol Exp Ther. 1968 Jul;162(1):92–100. [PubMed] [Google Scholar]
  14. Roth R. H., Stone E. A. The action of reserpine on noradrenaline biosynthesis in sympathetic nerve tissue. Biochem Pharmacol. 1968 Aug;17(8):1581–1590. doi: 10.1016/0006-2952(68)90218-9. [DOI] [PubMed] [Google Scholar]
  15. Simmonds M. A., Gillis C. N. Uptake of normetanephrine and norepinephrine by cocaine-treated rat heart. J Pharmacol Exp Ther. 1968 Feb;159(2):283–289. [PubMed] [Google Scholar]
  16. Starke K., Werner U., Schümann H. J. Wirkung von Angiotensin auf Funktion und Noradrenalinabgabe isolierter Kaninchenherzen in Ruhe und bei Sympathicusreizung. Naunyn Schmiedebergs Arch Pharmakol. 1969;265(2):170–186. [PubMed] [Google Scholar]
  17. ZIMMERMAN B. G., GOMEZ J. INCREASED RESPONSE TO SYMPATHETIC STIMULATION IN THE CUTANEOUS VASCULATURE IN PRESENCE OF ANGIOTENSIN. Int J Neuropharmacol. 1965 May;4:185–193. doi: 10.1016/0028-3908(65)90008-0. [DOI] [PubMed] [Google Scholar]
  18. Zimmerman B. G., Gisslen J. Pattern of renal vasoconstriction and transmitter release during sympathetic stimulation in presence of angiotensin and cocaine. J Pharmacol Exp Ther. 1968 Oct;163(2):320–329. [PubMed] [Google Scholar]
  19. von EULER U., LISHAJKO F. Improved technique for the fluorimetric estimation of catecholamines. Acta Physiol Scand. 1961 Apr;51:348–355. doi: 10.1111/j.1748-1716.1961.tb02128.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES